OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
Alexandra C. Walls, Kaitlin R. Sprouse, Anshu Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Alexandra C. Walls, Kaitlin R. Sprouse, Anshu Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Showing 9 citing articles:
Correlates of protection against SARS ‐CoV ‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern
Dale Kitchin, Simone I. Richardson, Mieke A. van der Mescht, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100535-100535
Open Access | Times Cited: 35
Dale Kitchin, Simone I. Richardson, Mieke A. van der Mescht, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100535-100535
Open Access | Times Cited: 35
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
Delphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Delphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 15
Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 15
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
Thandeka Moyo-Gwete, Simone I. Richardson, Roanne Keeton, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011772-e1011772
Open Access | Times Cited: 3
Thandeka Moyo-Gwete, Simone I. Richardson, Roanne Keeton, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011772-e1011772
Open Access | Times Cited: 3
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern
Dale Kitchin, Simone I. Richardson, Mieke A. van der Mescht, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Dale Kitchin, Simone I. Richardson, Mieke A. van der Mescht, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Serum anti-Spike antibody titers before and after heterologous booster with mRNA-1273 SARS-CoV-2 vaccine following two doses of inactivated whole-virus CoronaVac vaccine
Robert Sinto, Dwi Utomo, Suwarti Suwarti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Robert Sinto, Dwi Utomo, Suwarti Suwarti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Across-the-board review on Omicron SARS-CoV-2 variant
Rufaida Wasim, Sumaiya, Asad Maqbool Ahmad
Inflammopharmacology (2024)
Closed Access
Rufaida Wasim, Sumaiya, Asad Maqbool Ahmad
Inflammopharmacology (2024)
Closed Access
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
Thandeka Moyo-Gwete, Simone I. Richardson, Roanne Keeton, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Thandeka Moyo-Gwete, Simone I. Richardson, Roanne Keeton, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
